This revised renewal application is directed toward understanding the multifaceted role of the c-myc oncogene in human breast cancer. Our proposal focuses on elucidation of the mechanisms whereby c-Myc protein causes malignant behavior of human mammary epithelial cells. In a coordinated, translational research proposal, experiments will be conducted with primary and immortalized human mammary epithelial cell (HMEC) cultures in vitro and with archival human breast tumor specimens.
In Aim 1, we will determine how c-Myc-cell adhesion interactions regulate cell transformation (anchorage independent proliferation) in human mammary epithelial cells. We have shown that in immortalized HMECs, deregulated expression of c- Myc allows anchorage independent, G1/S cell cycle progression, closely associated with proteosome-mediated degradation of p27. We now use a newly established, regulatable MCF-10A-c-MycER system and non-immortalized HMEC to elucidate the mechanism and relevance for cell transformation of this effect. Experiments will determine the roles of SCFSKP2 ubiquitin ligase components, MAP kinases, and Jab1-dependent cytoplasmic localization of p27, in c-Myc triggered destruction of p27. In addition, experiments will establish downstream consequences of p27 destabilization for activation of CDK2 and inactivation of pRb for induction of anchorage independent cell proliferation.
In Aim 2, we will seek to confirm that the c-Myc-dependent mechanisms, observed in Aim 1 are relevant to human breast cancer.
This second Aim i s based on our demonstration that c-myc gene amplification correlates with its expression, commonly occurring in human breast cancer. In the previous grant period we reported a meta-analysis of the literature that strongly suggested that c-myc gene amplification is significantly associated with high grade, progesterone receptor negative disease (irrespective of estrogen receptor status). Importantly, c-myc amplification was significantly correlated with lymph node metastasis and poor disease free and overall survival.
In Aim 2, we will first determine whether deregulated expression of c-Myc preceeds its gene amplification, in the natural history of the disease. Second, we will determine whether tumor proliferation is correlated positively with c-Myc protein expression, negatively with p27, and positively with expression of mediators of p27 degradation: SCF SKP2 ubiquitin ligase and Jab1. Third, we will determine whether tumor apoptosis is correlated with proliferation, c-Myc and wild type p53. Finally, we will determine whether c-Myc amplification or expression is more closely correlated with poor clinical outcome. Thus, our new proposal builds on our prior funding period to further examine mechanisms of c-Myc-promoted malignancy in the human mammary epithelial cell in vitro and in human breast cancer in women.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG014963-08
Application #
7000334
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Sierra, Felipe
Project Start
1997-05-01
Project End
2008-12-31
Budget Start
2006-02-01
Budget End
2006-12-31
Support Year
8
Fiscal Year
2006
Total Cost
$340,993
Indirect Cost
Name
Georgetown University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Deb, Tushar B; Zuo, Annie H; Wang, Youhong et al. (2011) Pnck induces ligand-independent EGFR degradation by probable perturbation of the Hsp90 chaperone complex. Am J Physiol Cell Physiol 300:C1139-54
Coticchia, Christine M; Revankar, Chetana M; Deb, Tushar B et al. (2009) Calmodulin modulates Akt activity in human breast cancer cell lines. Breast Cancer Res Treat 115:545-60
Deb, Tushar B; Coticchia, Christine M; Barndt, Robert et al. (2008) Pregnancy-upregulated nonubiquitous calmodulin kinase induces ligand-independent EGFR degradation. Am J Physiol Cell Physiol 295:C365-77
Calvo, A; Catena, R; Noble, M S et al. (2008) Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene 27:5373-84
Rosfjord, E C; Dickson, R B (1999) Growth factors, apoptosis, and survival of mammary epithelial cells. J Mammary Gland Biol Neoplasia 4:229-37
Faris, M; Latinis, K M; Kempiak, S J et al. (1998) Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter. Mol Cell Biol 18:5414-24